z-logo
open-access-imgOpen Access
Should We Consider Value Frameworks for Cancer Drugs as Oncology's Landscape Evolves?; from an Oncologist Perspective in Korea
Author(s) -
Do Yeun Kim,
Hyerim Ha,
SeungJin Bae,
Jin Hyoung Kang
Publication year - 2021
Publication title -
journal of korean medical science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.743
H-Index - 66
eISSN - 1598-6357
pISSN - 1011-8934
DOI - 10.3346/jkms.2021.36.e191
Subject(s) - medicine , reimbursement , cancer , clinical oncology , oncology , personalized medicine , cancer drugs , drug development , precision medicine , family medicine , intensive care medicine , health care , drug , pharmacology , bioinformatics , pathology , economics , biology , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom